Kentucky Retirement Systems Insurance Trust Fund Cuts Stake in Xylem Inc. (NYSE:XYL)

Kentucky Retirement Systems Insurance Trust Fund lowered its position in shares of Xylem Inc. (NYSE:XYLFree Report) by 7.4% in the 1st quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 7,956 shares of the industrial products company’s stock after selling 633 shares during the period. Kentucky Retirement Systems Insurance Trust Fund’s holdings in Xylem were worth $1,028,000 as of its most recent filing with the Securities & Exchange Commission.

Several other hedge funds have also recently modified their holdings of XYL. FinTrust Capital Advisors LLC grew its holdings in shares of Xylem by 170.9% in the first quarter. FinTrust Capital Advisors LLC now owns 317 shares of the industrial products company’s stock worth $41,000 after acquiring an additional 200 shares during the period. Hazlett Burt & Watson Inc. grew its stake in shares of Xylem by 184.9% during the 1st quarter. Hazlett Burt & Watson Inc. now owns 339 shares of the industrial products company’s stock valued at $43,000 after purchasing an additional 220 shares during the period. Spire Wealth Management increased its position in shares of Xylem by 370.9% during the 4th quarter. Spire Wealth Management now owns 485 shares of the industrial products company’s stock valued at $54,000 after purchasing an additional 382 shares during the last quarter. Advantage Trust Co bought a new position in shares of Xylem in the 4th quarter worth approximately $57,000. Finally, Tompkins Financial Corp boosted its holdings in shares of Xylem by 26.9% in the first quarter. Tompkins Financial Corp now owns 533 shares of the industrial products company’s stock worth $69,000 after buying an additional 113 shares during the last quarter. Hedge funds and other institutional investors own 87.96% of the company’s stock.

Insiders Place Their Bets

In other news, SVP Rodney Aulick sold 21,800 shares of Xylem stock in a transaction that occurred on Wednesday, June 5th. The shares were sold at an average price of $139.01, for a total transaction of $3,030,418.00. Following the completion of the sale, the senior vice president now owns 76,287 shares of the company’s stock, valued at $10,604,655.87. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. In other Xylem news, CAO Geri-Michelle Mcshane sold 2,278 shares of the stock in a transaction dated Monday, June 10th. The shares were sold at an average price of $138.63, for a total transaction of $315,799.14. Following the transaction, the chief accounting officer now directly owns 3,536 shares in the company, valued at approximately $490,195.68. The sale was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Also, SVP Rodney Aulick sold 21,800 shares of Xylem stock in a transaction that occurred on Wednesday, June 5th. The shares were sold at an average price of $139.01, for a total transaction of $3,030,418.00. Following the transaction, the senior vice president now directly owns 76,287 shares in the company, valued at $10,604,655.87. The disclosure for this sale can be found here. Corporate insiders own 0.27% of the company’s stock.

Xylem Price Performance

Shares of NYSE:XYL traded up $0.62 during midday trading on Monday, reaching $141.46. 448,116 shares of the company were exchanged, compared to its average volume of 1,190,792. The stock has a market cap of $34.30 billion, a PE ratio of 50.17, a price-to-earnings-growth ratio of 2.50 and a beta of 1.04. The business’s fifty day moving average is $138.55 and its two-hundred day moving average is $130.53. Xylem Inc. has a one year low of $87.59 and a one year high of $146.08. The company has a current ratio of 1.67, a quick ratio of 1.22 and a debt-to-equity ratio of 0.19.

Xylem (NYSE:XYLGet Free Report) last released its quarterly earnings data on Thursday, May 2nd. The industrial products company reported $0.90 EPS for the quarter, beating the consensus estimate of $0.84 by $0.06. Xylem had a net margin of 8.34% and a return on equity of 8.95%. The business had revenue of $2.03 billion during the quarter, compared to the consensus estimate of $2 billion. During the same quarter in the prior year, the firm earned $0.72 EPS. The business’s revenue was up 40.4% on a year-over-year basis. As a group, analysts predict that Xylem Inc. will post 4.22 earnings per share for the current year.

Xylem Dividend Announcement

The company also recently declared a quarterly dividend, which was paid on Thursday, June 27th. Shareholders of record on Thursday, May 30th were issued a dividend of $0.36 per share. This represents a $1.44 annualized dividend and a yield of 1.02%. The ex-dividend date of this dividend was Thursday, May 30th. Xylem’s dividend payout ratio is presently 51.25%.

Wall Street Analyst Weigh In

A number of analysts have commented on the stock. Mizuho upped their target price on shares of Xylem from $110.00 to $135.00 and gave the company a “neutral” rating in a report on Friday, May 3rd. Oppenheimer upped their price objective on Xylem from $147.00 to $152.00 and gave the stock an “outperform” rating in a research note on Friday, May 31st. Argus lifted their target price on Xylem from $146.00 to $165.00 and gave the company a “buy” rating in a research report on Wednesday, May 29th. Robert W. Baird upped their price target on Xylem from $151.00 to $155.00 and gave the stock an “outperform” rating in a research report on Friday, May 3rd. Finally, Citigroup lifted their price objective on Xylem from $126.00 to $139.00 and gave the company a “neutral” rating in a research report on Monday, April 8th. Five equities research analysts have rated the stock with a hold rating and ten have issued a buy rating to the stock. According to data from MarketBeat.com, Xylem currently has an average rating of “Moderate Buy” and an average target price of $144.58.

Check Out Our Latest Research Report on XYL

Xylem Profile

(Free Report)

Xylem Inc, together with its subsidiaries, engages in the design, manufacture, and servicing of engineered products and solutions worldwide. It operates through four segments: Water Infrastructure, Applied Water, Measurement & Control Solutions, and Integrated Solutions and Services. The Water Infrastructure segment offers products, including water, storm water, and wastewater pumps; controls and systems; filtration, disinfection, and biological treatment equipment; and mobile dewatering equipment and rental services under the ADI, Flygt, Godwin, Sanitaire, Magneto, Neptune Benson, Ionpure, Leopold, Wedeco, and Xylem Vue brands.

Recommended Stories

Want to see what other hedge funds are holding XYL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Xylem Inc. (NYSE:XYLFree Report).

Institutional Ownership by Quarter for Xylem (NYSE:XYL)

Receive News & Ratings for Xylem Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Xylem and related companies with MarketBeat.com's FREE daily email newsletter.